Solvent exposures and Parkinson disease risk in twins

Annals of Neurology

Volumn 71, Issue 6, 2012, Pages 776-784

  Goldman, Samuel M ^a   Quinlan, Patricia J ^b   Ross, G Webster ^c   Marras, Connie ^d   Meng, Cheryl ^a   Bhudhikanok, Grace S ^a   Comyns, Kathleen ^a   Korell, Monica ^a   Chade, Anabel R ^e   Kasten, Meike ^f   Priestley, Benjamin ^a   Chou, Kelvin L ^g   Fernandez, Hubert H ^h   Cambi, Franca ⁱ   Langston, J William ^a   Tanner, Caroline M ^a  

^a PARKINSON S INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

^e FAVALORO UNIVERSITY   (Argentina)

^f UNIVERSITY OF LÜBECK   (Germany)

^g UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^h LERNER RESEARCH INSTITUTE   (United States)

ⁱ UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON TETRACHLORIDE; GROUND WATER; HEXANE; SOLVENT; TETRACHLOROETHYLENE; TOLUENE; TRICHLOROETHYLENE; XYLENE;

ADULT; AGED; ARTICLE; ENVIRONMENTAL EXPOSURE; HUMAN; INTERVIEW; LEISURE; MAJOR CLINICAL STUDY; MALE; OCCUPATION; PARKINSON DISEASE; POPULATION RESEARCH; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; TWINS;

ADULT; AGED; AGED, 80 AND OVER; CARBON TETRACHLORIDE; COHORT STUDIES; DISEASES IN TWINS; FEMALE; HUMANS; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; ODDS RATIO; PARKINSON DISEASE; RISK FACTORS; SOLVENTS; TETRACHLOROETHYLENE; TWINS;

EID: 84862765771     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.22629     Document Type: Article

References (72)

1. Guggenheim MA, Couch JR, Weinberg W. Motor dysfunction as a permanent complication of methanol ingestion. Presentation of a case with a beneficial response to levodopa treatment. Arch Neurol 1971;24:550-554.
2. Pezzoli G, Barbieri S, Ferrante C, et al. Parkinsonism due to n-hexane exposure. Lancet 1989;2:874.
3. McCrank E, Rabheru K. Four cases of progressive supranuclear palsy in patients exposed to organic solvents. Can J Psychiatry 1989;34:934-936.
4. Tetrud JW, Langston JW, Irwin I, Snow B. Parkinsonism caused by petroleum waste ingestion. Neurology 1994;44:1051-1054.
5. Uitti RJ, Snow BJ, Shinotoh H, et al. Parkinsonism induced by solvent abuse. Ann Neurol 1994;35:616-619.
6. Gash DM, Rutland K, Hudson NL, et al. Trichloroethylene: parkinsonism and complex 1 mitochondrial neurotoxicity. Ann Neurol 2008;63:184-192.
7. Guehl D, Bezard E, Dovero S, et al. Trichloroethylene and parkinsonism: a human and experimental observation. Eur J Neurol 1999;6:609-611.
8. Kochen W, Kohlmuller D, De Biasi P, Ramsay R. The endogeneous formation of highly chlorinated tetrahydro-beta-carbolines as a possible causative mechanism in idiopathic Parkinson's disease. Adv Exp Med Biol 2003;527:253-263.
9. International Agency for Research on Cancer. Monographs on the evaluation of carcinogenic risks to humans. Vol 63 Lyon, France: World Health Organization, 1997.
10. Agency for Toxic Substances and Disease Registry. Toxicological profile for trichloroethylene. Atlanta, GA: United States Department of Health and Human Services, 1997.
11. Hubinette A, Cnattingius S, Ekbom A, et al. Birthweight, early environment, and genetics: a study of twins discordant for acute myocardial infarction. Lancet 2001;357:1997-2001.
12. Jablon S, Neel JV, Gershowitz H, Atkinson GF. The NAS-NRC twin panel: methods of construction of the panel, zygosity diagnosis, and proposed use. Am J Hum Genet 1967;19:133-161.
13. Tanner CM, Ottman R, Goldman SM, et al. Parkinson disease in twins: an etiologic study. JAMA 1999;281:341-346.
14. Tanner C, Gilley D, Goetz C. A brief screening questionnaire for parkinsonism. Ann Neurol 1990;28:267-268.
15. Breitner JC, Welsh KA, Gau BA, et al. Alzheimer's disease in the National Academy of Sciences-National Research Council Registry of Aging Twin Veterans. III. Detection of cases, longitudinal results, and observations on twin concordance. Arch Neurol 1995;52:763-771.
16. Langston JW, Widner H, Goetz CG, et al. Core assessment program for intracerebral transplantations (CAPIT). Mov Disord 1992;7:2-13.
17. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
18. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999;56:33-39.
19. Stewart PA, Lees PS, Francis M. Quantification of historical exposures in occupational cohort studies. Scand J Work Environ Health 1996;22:405-414.
20. Siemiatycki J, Dewar R, Lakhani R, et al. Cancer risks associated with 10 inorganic dusts: results from a case-control study in Montreal. Am J Ind Med 1989;16:547-567.
21. Stewart P, Rice C, Beatty P, et al. A qualitative evaluation of questions and responses from five occupational questionnaires developed to assess exposures. Appl Occup Environ Hyg 2002;17:444-453.
22. Siemiatycki J, Gerin M, Dewar R, et al. Silica and cancer associations from a multicancer occupational exposure case-referent study. IARC Sci Publ 1990;(97):29-42.
23. Stewart PA, Stewart WF, Heineman EF, et al. A novel approach to data collection in a case-control study of cancer and occupational exposures. Int J Epidemiol 1996;25:744-752.
24. Katz EA, Shaw GM, Schaffer DM. Exposure assessment in epidemiologic studies of birth defects by industrial hygiene review of maternal interviews. Am J Ind Med 1994;26:1-11.
25. Burgess W. Recognition of health hazards in industry. 2nd ed. New York, NY: John Wiley & Sons, 1995.
26. Plog B, Quinlan PJ, eds.. Fundamentals of industrial hygiene. 5th ed. Itasca, IL: National Safety Council, 2002.
27. Stewart WF, Stewart PA. Occupational case-control studies: I. Collecting information on work histories and work-related exposures. Am J Ind Med 1994;26:297-312.
28. Harris RL, ed. Patty's industrial hygiene. 5th ed. New York, NY: John Wiley & Sons, 2000.
29. Stellman JM, ed. ILO encyclopedia of occupational health and safety. 4th ed. Geneva, Switzerland: International Labor Organization (ILO), 1998.
30. Siemiatycki J, Fritschi L, Nadon L, Gerin M. Reliability of an expert rating procedure for retrospective assessment of occupational exposures in community-based case-control studies. Am J Ind Med 1997;31:280-286.
31. Fritschi L, Nadon L, Benke G, et al. Validation of expert assessment of occupational exposures. Am J Ind Med 2003;43:519-522.
32. Moore LE, Boffetta P, Karami S, et al. Occupational trichloroethylene exposure and renal carcinoma risk: evidence of genetic susceptibility by reductive metabolism gene variants. Cancer Res 2010;70:6527-6536.
33. Gold LS, Stewart PA, Milliken K, et al. The relationship between multiple myeloma and occupational exposure to six chlorinated solvents. Occup Environ Med 2011;68:391-399.
34. Bringmann G, God R, Feineis D, et al. The TaClo concept: 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo), a new toxin for dopaminergic neurons. J Neural Transm Suppl 1995;46:235-244.
35. Lash LH, Fisher JW, Lipscomb JC, Parker JC. Metabolism of trichloroethylene. Environ Health Perspect 2000;108(suppl 2):177-200.
36. Lash LH, Parker JC. Hepatic and renal toxicities associated with perchloroethylene. Pharmacol Rev 2001;53:177-208.
37. Tanner CM, Goldman SM, Aston DA, et al. Smoking and Parkinson's disease in twins. Neurology 2002;58:581-588.
38. Goldman SM, Tanner CM, Oakes D, Bhudhikanok GS, Gupta A, Langston JW. Head injury and Parkinson's disease risk in twins. Ann Neurol 2006;60:65-72.
39. Gallo JJ, Breitner JC. Alzheimer's disease in the NAS-NRC Registry of aging twin veterans: IV. Performance characteristics of a two-stage telephone screening procedure for Alzheimer's dementia. Psychol Med 1995;25:1211-1219.
40. Liu M, Choi DY, Hunter RL, et al. Trichloroethylene induces dopaminergic neurodegeneration in Fisher 344 rats. J Neurochem 2010;112:773-783.
41. Braak H, Del Tredici K, Rub U, et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003;24:197-211.
42. Di Monte DA. Mitochondrial DNA and Parkinson's disease. Neurology 1991;41(5 suppl 2):38-42; discussion 42-43.
43. Sherer TB, Richardson JR, Testa CM, et al. Mechanism of toxicity of pesticides acting at complex I: relevance to environmental etiologies of Parkinson's disease. J Neurochem 2007;100:1469-1479.
44. Miyazaki Y, Takano T. Impairment of mitochondrial electron transport by tetrachloroethylene. Toxicol Lett 1983;18:163-166.
45. Lash LH, Qian W, Putt DA, et al. Renal toxicity of perchloroethylene and S-(1,2,2-trichlorovinyl)glutathione in rats and mice: sexand species-dependent differences. Toxicol Appl Pharmacol 2002;179:163-171.
46. Boer LA, Panatto JP, Fagundes DA, et al. Inhibition of mitochondrial respiratory chain in the brain of rats after hepatic failure induced by carbon tetrachloride is reversed by antioxidants. Brain Res Bull 2009;80:75-78.
47. Weber LW, Boll M, Stampfl A. Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model. Crit Rev Toxicol 2003;33:105-136.
48. Manibusan MK, Odin M, Eastmond DA. Postulated carbon tetrachloride mode of action: a review. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2007;25:185-209.
49. Ou J, Ou Z, McCarver DG, et al. Trichloroethylene decreases heat shock protein 90 interactions with endothelial nitric oxide synthase: implications for endothelial cell proliferation. Toxicol Sci 2003;73:90-97.
50. Lam HR, Ostergaard G, Guo SX, et al. Three weeks' exposure of rats to dearomatized white spirit modifies indices of oxidative stress in brain, kidney, and liver. Biochem Pharmacol 1994;47:651-657.
51. Lopachin RM, Gavin T, Barber DS. Type-2 alkenes mediate synaptotoxicity in neurodegenerative diseases. Neurotoxicology 2008;29:871-882.
52. Kim MS, Park HR, Park M, et al. Neurotoxic effect of 2,5-hexanedione on neural progenitor cells and hippocampal neurogenesis. Toxicology 2009;260:97-103.
53. Al-Hajri Z, Del Bigio MR. Brain damage in a large cohort of solvent abusers. Acta Neuropathol 2010;119:435-445.
54. Wu C, Schaum J. Exposure assessment of trichloroethylene. Environ Health Perspect 2000;108(suppl 2):359-363.
55. United States Environmental Protection Agency. Toxic release inventory program. Available at: http://www.epa.gov/tri/index.htm. Accessed November 5, 2010.
56. Agency for Toxic Substances and Disease Registry. Toxicological profile for tetrachloroethylene. Atlanta, GA: United States Department of Health and Human Services, 1997.
57. Agency for Toxic Substances and Disease Registry. Toxicological profile for carbon tetrachloride. Atlanta, GA: United States Department of Health and Human Services, 2005.
58. Linn B. Chemicals used in dry cleaning operations. 2009. Available at: http://www.drycleancoalition.org/chemicals/ChemicalsUsedInDrycleaning Operations.pdf
59. Riederer P, Foley P, Bringmann G, et al. Biochemical and pharmacological characterization of 1-trichloromethyl-1,2,3,4-tetrahydrobeta-carboline: a biologically relevant neurotoxin? Eur J Pharmacol 2002;442:1-16.
60. Heim C, Sontag KH. The halogenated tetrahydro-beta-carboline "TaClo": a progressively-acting neurotoxin. J Neural Transm Suppl 1997;50:107-111.
61. Park RM, Schulte PA, Bowman JD, et al. Potential occupational risks for neurodegenerative diseases. Am J Ind Med 2005;48:63-77.
62. McDonnell L, Maginnis C, Lewis S, et al. Occupational exposure to solvents and metals and Parkinson's disease. Neurology 2003;61:716-717.
63. Tanner CM, Ross GW, Jewell SA, et al. Occupation and risk of parkinsonism: a multicenter case-control study. Arch Neurol 2009;66:1106-1113.
64. Dick FD, De Palma G, Ahmadi A, et al. Environmental risk factors for Parkinson's disease and parkinsonism: the Geoparkinson study. Occup Environ Med 2007;64:666-672.
65. Firestone JA, Lundin JI, Powers KM, et al. Occupational factors and risk of Parkinson's disease: a population-based case-control study. Am J Ind Med 2010;53:217-223.
66. Lam HR, Ostergaard G, Ladefoged O. Three weeks' and six months' exposure to aromatic white spirit affect synaptosomal neurochemistry in rats. Toxicol Lett 1995;80:39-48.
67. Mattia CJ, Ali SF, Bondy SC. Toluene-induced oxidative stress in several brain regions and other organs. Mol Chem Neuropathol 1993;18:313-328.
68. Baydas G, Ozveren F, Tuzcu M, Yasar A. Effects of thinner exposure on the expression pattern of neural cell adhesion molecules, level of lipid peroxidation in the brain and cognitive function in rats. Eur J Pharmacol 2005;512:181-187.
69. Mutti A, Franchini I. Toxicity of metabolites to dopaminergic systems and the behavioural effects of organic solvents. Br J Ind Med 1987;44:721-723.
70. Hepworth SJ, Bolton A, Parslow RC, et al. Assigning exposure to pesticides and solvents from self-reports collected by a computer assisted personal interview and expert assessment of job codes: the UK Adult Brain Tumour Study. Occup Environ Med 2006;63:267-272.
71. Blair A, Zahm SH. Methodologic issues in exposure assessment for case-control studies of cancer and herbicides. Am J Ind Med 1990;18:285-293.
72. McGuire V, Nelson LM, Koepsell TD, et al. Assessment of occupational exposures in community-based case-control studies. Annu Rev Public Health 1998;19:35-53.